Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for People With Psychosis (EviBaS)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02974400 |
Recruitment Status :
Completed
First Posted : November 28, 2016
Last Update Posted : May 9, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Schizophrenia Hallucinations Persecutory Delusion | Behavioral: Internet-based, CBT-oriented, guided self-help | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 101 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for Persecutory Ideation and Auditory Verbal Hallucinations |
Actual Study Start Date : | December 6, 2016 |
Actual Primary Completion Date : | April 16, 2019 |
Actual Study Completion Date : | April 16, 2019 |

Arm | Intervention/treatment |
---|---|
Experimental: Internet-based guided self-help
Internet-based, guided, CBT-oriented self-help treatment for persecutory ideation and auditory verbal hallucinations with access to a self-help website including regular written electronic contact with a guide and access to smartphone-based interactive worksheets (8 weeks)
|
Behavioral: Internet-based, CBT-oriented, guided self-help
The self-help program includes sessions regarding (1) cognitive model, (2) sleep hygiene, (3) mindfulness, (4) meta-cognition, (5) coping with voice hearing, (6) persecutory ideation, (7) worrying, (8) self-esteem, (9) depression, (10) social competence, and (11) relapse prevention. |
No Intervention: Wait-List
Wait-list control group (8 weeks)
|
- Positive and Negative Syndrome Scale (PANSS) [ Time Frame: Change in PANSS from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module) ]Kay et al. (1987); clinician administered
- Paranoia Checklist (PC) [ Time Frame: Change in PC from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module) ]Freeman et al. (2005); self-report
- Launay-Slade Hallucination Scale (LSHS) [ Time Frame: Change in LSHS from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module) ]Bentall & Slade (1985); self-report
- Patient Health Questionnaire (PHQ-9) [ Time Frame: Change in PHQ-9 from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module) ]Spitzer, Kroenke & Williams, 1999; self-report
- Incongruence Scale (INK) [ Time Frame: Change in INK from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module) ]Grosse Holtforth, Grawe & Tamcan (2004); self-report
- Quality of life (WHO-QOL) [ Time Frame: Change in WHO-QOL from pre-intervention to post-intervention (i.e. between 1 and 7 days after completion of the last module) ]WHO; self-report

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Electronic informed consent
- Internet access
- Adequate command of the German language
- PANSS Suspiciousness/persecution >= 3 AND/OR PANSS hallucinations >=3
- Diagnosis of schizophrenia, schizoaffective disorder or delusional disorder
- Concurrent psychopharmacological treatment
Exclusion Criteria:
- Acute suicidality
- Acute risk of endangering others
- No emergency plan (with is formulated during the telephone interview)
- Disease of the central nervous system with need for treatment

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02974400
Germany | |
University Medical Center Hamburg-Eppendorf | |
Hamburg, Germany, 20246 | |
Switzerland | |
University of Bern | |
Bern, Switzerland, 3012 |
Principal Investigator: | Stefan Westermann, Dr | University of Bern | |
Principal Investigator: | Steffen Moritz, Prof. Dr. | Universitätsklinikum Hamburg-Eppendorf |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | University of Bern |
ClinicalTrials.gov Identifier: | NCT02974400 |
Other Study ID Numbers: |
159384 |
First Posted: | November 28, 2016 Key Record Dates |
Last Update Posted: | May 9, 2019 |
Last Verified: | May 2019 |
internet-based intervention e-mental health cognitive behavioural intervention |
Hallucinations Schizophrenia Delusions Schizophrenia Spectrum and Other Psychotic Disorders Mental Disorders |
Perceptual Disorders Neurobehavioral Manifestations Neurologic Manifestations Nervous System Diseases Behavioral Symptoms |